4BaseCare

4BaseCare is a biotech company in Singapore, Singapore, founded in 2018. It has raised $21.4M across 2 rounds, most recently a $15.4M Series B in June 2026.

Harnessing genomic diversity and AI to personalize cancer care

Headquarters
Singapore
Employees
201–500
Founded
2018
Business Model
B2B
Total Funding
$21.4M
Last Round
$15.4M Series BJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

4BaseCare is an Illumina-backed precision oncology company headquartered in Singapore, developing cutting-edge genomic solutions to personalize cancer care for patients globally. Founded in 2018, the company combines advanced next-generation sequencing (NGS), AI-powered analytics, and real-world clinical data through its OncoTwin platform, which provides clinical decision support, AI-enhanced molecular tumor board intelligence, and clinical trial optimization. 4BaseCare has built the world's first Global Cancer Diversity Atlas—capturing genomic diversity from underrepresented populations across 15+ countries—and offers a comprehensive suite of genomic tests including tissue profiling, liquid biopsy, SoLiQ dual-source genomics, HRD testing, and germline cancer risk assessment. The company serves clinicians across 70+ cancer types and is committed to making precision oncology accessible and affordable across India, Southeast Asia, and the Middle East.

Summary

It lists 201–500 employees. It has raised $21.4M in total across 2 rounds, most recently a $15.4M Series B round in Jun 2026. Investors include GrowX Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJun 2026
$15.4M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

4BaseCare on Indexed.vc
<a href="https://indexed.vc/companies/4basecare"><img src="https://indexed.vc/api/badge/company/4basecare" alt="4BaseCare on Indexed.vc" width="260" height="76" /></a>